Form 4: Castle Biosciences CFO Sells Shares
Insider Transaction (Form 4)
Frank Stokes, Chief Financial Officer of Castle Biosciences Inc, sold 24,908 shares of common stock on August 14, 2026 for $29.77 per share.
Summary
- Open-market sale: disposed of 24,908 Common Stock at $29.77 ($741,511) on August 14, 2026; holds 35,177 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $741,511 of stock on the open market.
Insider Transactions
Frank Stokes — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Open-market sale | Common Stock | 24,908 | $30 | $741.5K | 35,177 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Open-market sale (24,908 shares) |
Keywords
insider transaction, Form 4, CSTL, CASTLE BIOSCIENCES INC, bearish, Frank Stokes
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.